Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2003
08/14/2003US20030153654 Macromolecular hals with a definite molecular weight
08/14/2003US20030153606 Antiproliferative agents for treating adipocyte differentiation, cancer, osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease
08/14/2003US20030153604 Anticoagulants
08/14/2003US20030153597 Therapeutic treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease, nervous system disorders and cardiovascular disorders
08/14/2003US20030153588 Such as N-butyl-2-(4-(4-chloro-3-methoxyphenyl)-5-pyridin-4-yl-1H-imidazole-2 -yl)isobutylamide for treatment of neurotraumatic disorders
08/14/2003US20030153583 Solid-state forms of N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl) pyrazole
08/14/2003US20030153580 Cis-imidazolines
08/14/2003US20030153577 Cyclic amine derivatives-CCR-3 receptor antagonists
08/14/2003US20030153573 Novel N-substituted 4-((-4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties
08/14/2003US20030153569 Novel pyrazole and pyrazoline substituted compounds
08/14/2003US20030153560 Fused n-heterocylic derivatives; mitogen-activated protein kinase inhibitors
08/14/2003US20030153555 Novel compounds
08/14/2003US20030153553 Quinoline derivatives
08/14/2003US20030153510 Novel compounds inhibiting factor xa activity
08/14/2003US20030153508 Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
08/14/2003US20030152520 5-Substituted-2-arylpyridines
08/14/2003CA2737565A1 N-phenyl-2-pyrimidine-amine derivatives
08/14/2003CA2486446A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
08/14/2003CA2478423A1 Gamma secretase inhibitors
08/14/2003CA2475336A1 Novel tetrazole derivative useful as herbicides
08/14/2003CA2475320A1 Quinoxalinones and their use especially in the treatment of cardiovascular diseases
08/14/2003CA2474687A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of thereof as medicaments
08/14/2003CA2474508A1 Ansamycins having improved pharmacological and biological properties
08/14/2003CA2474214A1 Novel aryl- and heteroarylpiperazines
08/14/2003CA2474168A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003CA2473181A1 Quinoline derivatives as npy antagonists
08/14/2003CA2467555A1 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl)-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-me thyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
08/13/2003EP1334971A1 Benzimidazole compounds, process for producing the same and use thereof
08/13/2003EP1334102A1 Bombesin receptor antagonists
08/13/2003EP1334100A1 Bombesin receptor antagonists
08/13/2003EP1334099A4 Herbicidally active pyridine sulfonyl urea derivatives
08/13/2003EP1334099A1 Herbicidally active pyridine sulfonyl urea derivatives
08/13/2003EP1334098A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
08/13/2003EP1334089A1 Quinoline derivatives as nk-3 and nk-2 antagonists
08/13/2003EP1333834A2 Antiinflammation agents
08/13/2003EP1333831A2 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors
08/13/2003EP1333829A1 Treatment of sexual dysfunction using bombesin antagonists
08/13/2003EP1333824A2 Treatment of sexual dysfunction
08/13/2003EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists
08/13/2003EP1220845B1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors
08/13/2003EP1073658B1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
08/13/2003EP1034174B1 Azaring-ether derivatives and their use as nicotinic ach receptor modulators
08/13/2003EP0976745B1 4-tetrahydropyridylpyrimidine derivatives
08/13/2003EP0945435B1 Novel pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient
08/13/2003EP0927179B1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
08/13/2003EP0901478B1 Thiocyano-triazolyl derivatives and their use as microbicides
08/13/2003EP0901477B1 Sulphonyl-mercapto-triazolyl derivatives and their use as microbicides
08/13/2003EP0885888B1 Isoquinoline derivatives and drugs
08/13/2003EP0879233B1 Chinoline and benzimidazole derivatives as bradykinin agonists
08/13/2003EP0808313B1 Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
08/13/2003CN1436184A Substd. pyridine herbicides
08/13/2003CN1436175A Cyclic lactams as inhibitors of A beta-protein production
08/13/2003CN1436172A 1,2-dihydropyridine compounds, process for preparation of same and use thereof
08/13/2003CN1436077A Stabilized pharmaceutical compositions contg. calcium channel blockers
08/13/2003CN1117748C Herbicidal 2,6-disubstd. pyridines and 2,4-disubstd. pyrimidines
08/13/2003CN1117747C Method of preparation of optical purity lansoprazole
08/13/2003CN1117746C Method for preparing substd. pyridines and pyridines obtained thereby
08/13/2003CN1117745C Noval tricyclic N-cyanoimines useful as inhibitors of farnesyl-protein transferase
08/13/2003CN1117744C 1-(1,2-disubstd. piperidinyl)-4-substd. piperazine derivs.
08/13/2003CN1117569C Bicyclic fibrinogen antagonists
08/13/2003CN1117568C Gastrokinetic bicyclie benzamides of 3-or 4-substd. 4-(aminomethyl)-piperidine derivs.
08/12/2003US6605725 Treating a central or peripheral nervous system disorder or condition through modulation of a voltage-dependent potassium channel
08/12/2003US6605722 Tyrosine derivatives with anti-leukotrienen activity
08/12/2003US6605634 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605631 Ortho-substituted 2-methoxyiminophenyl-N-methylacetamides
08/12/2003US6605626 Antithrombotic agents
08/12/2003US6605623 Prevention of asthma and other allergic diseases
08/12/2003US6605620 Cyclic amine compounds and pharmaceutical composition containing the same
08/12/2003US6605618 Antidiabetic agents; hypoglycemic agents; anticholesterol agents; side effect reduction
08/12/2003US6605617 Treating a patient in need of an inhibitor of vascular endothelial growth factor receptor tyrosine kinase
08/12/2003US6605610 Aryl fused azapolycyclic compounds
08/12/2003US6605607 Antihypertensives; hyperprolactinaemia related conditions; certain central nervous system disorders
08/12/2003US6605604 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
08/12/2003US6605303 Oral pharmaceutical extended release dosage form
08/12/2003US6605201 Charge transfer compounds comprising osmium compounds coupled to polymers, used as biosensors
08/12/2003US6605200 Polymeric transition metal complexes and uses thereof
08/12/2003CA2277473C Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
08/07/2003WO2003064425A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/07/2003WO2003064413A1 Quinazoline compounds
08/07/2003WO2003064410A1 Novel 1,2,4-triazole compound
08/07/2003WO2003064409A1 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
08/07/2003WO2003064397A1 Indazole compounds useful as protein kinase inhibitors
08/07/2003WO2003064385A2 Delta1-pyrrolines and their use as pest control agents
08/07/2003WO2003064376A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
08/07/2003WO2003063874A1 Condensed heterocyclic compounds
08/07/2003WO2003063861A1 Fibrosis inhibitor
08/07/2003WO2003063844A2 Treatment of rheumatoid arthritis using imatinie
08/07/2003WO2003063840A2 Transmucosal delivery of proton pump inhibitors
08/07/2003WO2003063794A2 2,4-pyrimidinediamine compounds and their uses
08/07/2003WO2003030886A3 Allylamides useful in the treatment of alzheimer's disease
08/07/2003US20030149277 Triarylimidazole derivatives as cytokine inhibitors
08/07/2003US20030149266 Administering to a patient (a warm blooded animal, such as man) an effective amount of a pyrimidine derivative for treating cancer, cell proliferation, and inhibition of focal adhesion kinase effect
08/07/2003US20030149262 Benzodiazepine vitronectin receptor antagonist pharmaceuticals
08/07/2003US20030149143 Polyolefins, especially polypropylene, can be made flame retardant by the incorporation therein of a synergistic mixture of a selected hindered amine compound
08/07/2003US20030149081 For therapy and prophylaxis of asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, inflammatory bowel disease, atherosclerosis
08/07/2003US20030149075 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
08/07/2003US20030149074 Modulators of phosphoinositide 3-kinase
08/07/2003US20030149064 Pyrimidine compounds
1 ... 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 ... 1080